Figure 9. The mechanism graph of the regulatory network of PIEZO2 under different circumstance including normal (A) and cancer (B). In patients with breast cancer, miRNAs (miR-454-3p, miR-196a-5p, miR-301a-3p, miR-130b-3p and miR-421)-mediated downregulation of PIEZO2 can activate hedgehog signaling pathway by suppressing CDON.